Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. | Lancet Gastroenterol Hepatol | 2025 | 39521016 | PubTator, text mining | PubMed |
| hnRNPA2B1 deacetylation by SIRT6 restrains local transcription and safeguards genome stability. | Cell Death Differ | 2025 | 39511404 | PubTator, text mining | PubMed |
| Aerobic exercise alleviates statin-induced PCSK9 upregulation by increasing epoxyeicosatrienoic acid levels through the FoxO3a-Sirt6 axis. | J Sport Health Sci | 2025 | 39510317 | PubTator, text mining | PubMed |
| The SIRT6/BAP1/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI. | Cell Signal | 2025 | 39455033 | PubTator, text mining | PubMed |
| Oral administration of astilbin mitigates acetaminophen-induced acute liver injury in mice by modulating the gut microbiota. | Acta Pharmacol Sin | 2025 | 39313515 | PubTator, text mining | PubMed |
| Correction to: SIRT6 Improves Hippocampal Neurogenesis Following Prolonged Sleep Deprivation Through Modulating Energy Metabolism in Developing rats. | Mol Neurobiol | 2025 | 39052187 | PubTator, text mining | PubMed |
| Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence by alleviating oxidative damage and regulating intestinal metabolism. | J Adv Res | 2025 | 39029900 | PubTator, text mining | PubMed |
| Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation. | Cell Oncol (Dordr) | 2025 | 38954215 | PubTator, text mining | PubMed |
| The age-related decline of helicase function-how G-quadruplex structures promote genome instability. | FEBS Lett | 2025 | 38803008 | PubTator, text mining | PubMed |
| Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression. | Int J Mol Sci | 2024 | 39796040 | PubTator, text mining | PubMed |
| [Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium.] | Adv Gerontol | 2024 | 39742404 | PubTator, text mining | PubMed |
| [Gly14]-Humanin ameliorates high glucose-induced endothelial senescence via SIRT6. | Sci Rep | 2024 | 39730568 | PubTator, text mining | PubMed |
| Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction. | Sci Rep | 2024 | 39730461 | PubTator, text mining | PubMed |
| SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer. | Cell Biosci | 2024 | 39709438 | PubTator, text mining | PubMed |
| Correction: Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia-reperfusion injury: unfolding new epigenetic frontiers. | Clin Epigenetics | 2024 | 39707429 | PubTator, text mining | PubMed |
| Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications. | Cancers (Basel) | 2024 | 39682281 | PubTator, text mining | PubMed |
| The deacetylase SIRT6 reduces amyloid pathology and supports cognition in mice by reducing the stability of APP in neurons. | Sci Signal | 2024 | 39656860 | PubTator, text mining | PubMed |
| Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer. | J Med Chem | 2024 | 39631827 | PubTator, text mining | PubMed |
| Hepatic SIRT6 protects against cholestatic liver disease primarily via inhibiting bile acid synthesis. | J Biomed Res | 2024 | 39618181 | PubTator, text mining | PubMed |
| Circular Engineered Sortase for Interrogating Histone H3 in Chromatin. | J Am Chem Soc | 2024 | 39585806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=16